Search Results 331-340 of 17268 for egfr
Patients must have an eGFR of ≥20 mL/min/1.73m2, using the 4-variable Modification of Diet in Renal Disease equation in which eGFR = 175 x (SCr(mg/dL))- ...
Has confirmation that EGFR-, ALK-, or ROS1-directed therapy is not indicated as primary therapy (documentation of the absence of tumor-activating EGFR ...
... (eGFR ≥ 60ml/min). Study Of 225Ac-ABD147 To Establish Optimal Dose In Patients With SCLC And LCNEC Of The Lung That Previously Received Platinum-based ...
Primary renal impairment (estimated GFR [eGFR] <30 ml/min). Participating Mayo Clinic locations. Study statuses change often. Please contact the study team ...
* eGFR ≥ 30 mL/min/1.73 m2 * Must be vaccinated for S pneumoniae prior to randomization * Must be vaccinated for H influenzae type B (where available) ...
NOTE: Patients who have progressed on a prior EGFR inhibitor will meet this criterion. ... Patient must not have been previously treated with a KRAS G12C ...
Subjects with acute kidney injury or renal insufficiency (eGFR of <20 ml/min/1.73 m^2) as they are at increased risk of Nephrogenic Systemic Fibrosis following ...
Patient has normal renal function as defined by an estimated glomerular filtration rate (eGFR). > 60 mL/min/1.73 m^2, calculated as eGFR = 0.413 x (height ...
eGFR ≤ 60 (7, 8); History of prior moderate or severe contrast reaction including unresponsiveness, severe respiratory distress, convulsions, arrhythmia ...
* Known actionable genomic alterations (EGFR, ALK, ROS1, and BRAF V600E) or genes for which first-line approved therapies are available. * For non-squamous ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.